<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>The Coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), exhibits a wide spectrum of manifestations, from asymptomatic presentations to acute respiratory failure, myocardial injury, arterial or venous thrombosis, multiorgan failure, and death. Although COVID-19 mainly disrupts the respiratory syndrome, it has been shown to have detrimental impact on cardiac morphology and function, resulting in a broad range of cardiovascular complications and poor outcome, increasing morbidity and mortality of these patients. This review will summarize the knowledge on characterization of myocardial injury in COVID 19, by using cardiac biomarkers, electrocardiographic, and cardiac multi-modality imaging findings for an early and accurate diagnosis, proper management, correct treatment, and follow-up of COVID-19 patients.</p>
</abstract>

The Coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), exhibits a wide spectrum of manifestations, from asymptomatic presentations to acute respiratory failure, myocardial injury, arterial or venous thrombosis, multiorgan failure, and death. Although COVID-19 mainly disrupts the respiratory syndrome, it has been shown to have detrimental impact on cardiac morphology and function, resulting in a broad range of cardiovascular complications and poor outcome, increasing morbidity and mortality of these patients. This review will summarize the knowledge on characterization of myocardial injury in COVID 19, by using cardiac biomarkers, electrocardiographic, and cardiac multi-modality imaging findings for an early and accurate diagnosis, proper management, correct treatment, and follow-up of COVID-19 patients.

Multimodality diagnosis of cardiac involvement in COVID-19 patients

„Carol Davila” University of Medicine and Pharmacy

Romanian Journal of Cardiology

This work is licensed under the Creative Commons Attribution 4.0 International License.

{"article-title":"Multimodality diagnosis of cardiac involvement in COVID-19 patients"}

The Coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), exhibits a wide spectrum of...

Multimodality diagnosis of cardiac involvement in COVID-19 patients

Article Category: Review

Publié en ligne: 30 avr. 2022

Pages: 17 - 26

DOI: https://doi.org/10.47803/rjc.2021.31.1.17

Mots clés
COVID-19, myocardial injury, cardiac biomarkers, electrocardiogram, cardiac imaging

© 2021 Anca Balinisteanu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Figure 1

Figure 2

Figure 3

Figure 4

Multimodality diagnosis of cardiac involvement in COVID-19 patients

Article Category: Review

Publié en ligne: 30 avr. 2022

Pages: 17 - 26

DOI: https://doi.org/10.47803/rjc.2021.31.1.17

Mots clésCOVID-19, myocardial injury, cardiac biomarkers, electrocardiogram, cardiac imaging

© 2021 Anca Balinisteanu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Figure 1

Figure 2

Figure 3

Figure 4

Mots clés
COVID-19, myocardial injury, cardiac biomarkers, electrocardiogram, cardiac imaging